Episode Summary
Design Space InPharmatics Senior Program Management Consultant, Judy Magruder joins the show to share her vast experience consulting with biopharmaceutical product development organizations. In this episode, Ed, Brian, Meranda and Judy discuss how to approach early stage drug development, how to be flexible in the wake of regulatory challenges, instances where companies should pivot and the vital need for effective communication.
What We Covered
- 02:10 – Judy Magruder joins the show to discuss her background in early stage drug development and best practices for creating integrated product plans
- 06:21 – Judy provides her insights on CMC and the importance of identifying effective ways of executing strategy shifts in this ever-changing industry
- 13:09 – Other communication tools early stage companies can use to meet milestones
- 14:39 – How to manage expectations and risks as a CMO or head of an early stage drug development company
- 21:52 – Judy expounds on CMC regulatory challenges that early stage companies face and the importance of developing a plan
- 26:58 – Ed, Brian and Meranda thank Judy for joining the show
Tweetable Quotes
Links Mentioned
International Council fo Harmonisation
Leadership
Design Space InPharmatics – LinkedIn
Design Space InPharmatics – Twitter
Edward Narke on LinkedIn
Judy Magruder on LinkedIn